Why it was recalled
cMGP Deviations: Drug products repackaged into pouches without supporting stability studies.
Product description
Phentermine, 30 mg capsules, Rx only, Distributed by: Calvin Scott & Co. Inc. Albuquerque, NM 87123; MFG. Lannett Company, Philadelphia, PA 19136, NDC 00527-0597-10
Lot numbers, UPCs & expiration codes
Lot #: CS19309, CS20098, Exp 12/21
Where it was sold
Repacked drug products distributed to 12 physician consignees located in the following states: CA, ID, IL,OK, RI
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0011-2021
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Sep 16, 2020
- FDA report date
- Oct 14, 2020
- Quantity
- N/A
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Calvin Scott & Company, Inc.
Original FDA data
Every field from FDA enforcement report D-0011-2021, exactly as published.
Show all FDA fields
- City
- Albuquerque
- State
- NM
- Status
- Terminated
- Country
- United States
- Event ID
- 86442
- Address
- 209 Eubank Blvd Ne
- Code information
- Lot #: CS19309, CS20098, Exp 12/21
- Postal code
- 87123-2745
- Report date
- Oct 14, 2020
- Product type
- Drugs
- Recall number
- D-0011-2021
- Classification
- Class II
- Recalling firm
- Calvin Scott & Company, Inc.
- Termination date
- Apr 22, 2024
- Reason for recall
- cMGP Deviations: Drug products repackaged into pouches without supporting stability studies.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Phentermine, 30 mg capsules, Rx only, Distributed by: Calvin Scott & Co. Inc. Albuquerque, NM 87123; MFG. Lannett Company, Philadelphia, PA 19136, NDC 00527-0597-10
- Distribution pattern
- Repacked drug products distributed to 12 physician consignees located in the following states: CA, ID, IL,OK, RI
- Recall initiation date
- Sep 16, 2020
- Initial firm notification
- Letter
- Center classification date
- Oct 2, 2020